Evolution of PRP attendance at annual GRAPPA meetings from 2013 to 2017.
| Characteristic | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|
| PRP attending, n (first-time attendees, n) | 7 (6) | 8 (3) | 8 (0) | 11 (4) | 12 (2) |
| Males, n (%) | 3 (43) | 4 (50) | 4 (50) | 5 (45) | 6 (50) |
| Racial/ethnic composition, n (%) | |||||
| Asian | 1 (14) | 1 (13) | 1 (13) | 2 (18) | 2 (17) |
| White | 6 (86) | 7 (87) | 7 (87) | 8 (73) | 9 (75) |
| Latin American | — | — | — | 1 (9) | 1 (8) |
| Geographical representation, n (%) | |||||
| Asia | — | — | — | 1 (9) | 1 (8) |
| Europe | 4 (50) | 3 (38) | 3 (38) | 3 (27) | 4 (33) |
| North America | 4 (50) | 5 (62) | 5 (62) | 6 (55) | 6 (50) |
| South America | — | — | — | 1 (9) | 1 (8) |
PRP: patient research partners; GRAPPA: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis.